Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$3.28M Buy
323,116
+774
+0.2% +$8.59K ﹤0.01% 2441
2014
Q2
$4.05M Buy
322,342
+61,440
+24% +$708K ﹤0.01% 2148
2014
Q1
$2.86M Buy
260,902
+4,897
+2% +$48.7K ﹤0.01% 2416
2013
Q4
$2.66M Buy
256,005
+88,710
+53% +$934K ﹤0.01% 2527
2013
Q3
$1.84M Sell
167,295
-6,882
-4% -$71.8K ﹤0.01% 2676
2013
Q2
$1.65M Buy
+174,177
New +$1.53M ﹤0.01% 2765

Other funds holding CLS

UBS's CLS Position: Q3 2014 in Review

UBS increased its Celestica (CLS) stake by 0.24% in Q3 2014, buying an estimated $8.59K and bringing the position to 323,116 shares worth $3.28M. The position accounts for ﹤0.01% of the portfolio, ranked #2441.

UBS first reported a position in CLS in Q2 2013 and has held it in 6 quarters since. The position peaked at $4.05M in Q2 2014. 108 funds tracked by Wall St. Rank hold CLS as of Q3 2014.

  • UBS held 323,116 shares of Celestica worth $3.28M as of Q3 2014.
  • UBS bought 774 Celestica shares in Q3 2014, an estimated $8.59K.
  • Celestica made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2441 holding.
  • UBS first reported a position in Celestica in Q2 2013 and has held it in 6 quarters since.
  • UBS's Celestica position peaked at $4.05M in Q2 2014.
  • 108 funds tracked by Wall St. Rank held Celestica as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.